Carolina Colli Cruz, MD

MD Anderson Cancer Center

Poster(s):

• P2036 - Aggressive Behavior of Immune-Mediated Toxicities Following Immune Checkpoint Inhibitor Therapy Rechallenge
  Monday, October 28, 2024

  10:30 AM – 4:00 PM ET

• P3653 - Randomized Clinical Trial of Infliximab Versus Vedolizumab for Immune Checkpoint Inhibitor Related Colitis
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P3759 - Eosinophilic Colitis: A Novel Aggressive Endoscopic Presentation and Its Successful Therapeutic Management
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P4340 - Mystery Diarrhea: A Comparative Analysis of Immune-Mediated Colitis Disease Characteristics Among Patients With and Without Signs of Inflammation on Initial Work-Up
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET